MedPath

Medimetriks Pharmaceuticals, Inc.

Medimetriks Pharmaceuticals, Inc. logo
🇹🇹Trinidad and Tobago
Ownership
Subsidiary
Established
2008-01-01
Employees
101
Market Cap
-
Website
http://www.medimetriks.com

Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis

Phase 2
Completed
Conditions
Atopic Dermatitis
Interventions
Drug: MM36 topical ointment, 1%
First Posted Date
2016-10-26
Last Posted Date
2018-11-19
Lead Sponsor
Medimetriks Pharmaceuticals, Inc
Target Recruit Count
32
Registration Number
NCT02945657
Locations
🇵🇦

Medimetriks Investigational Site, Panama City, Panama

© Copyright 2025. All Rights Reserved by MedPath